No abstract

No abstract

No abstract

No abstract

Dysregulation of the inflammatory response system has been linked to pathophysiology of schizophrenia. 1,2 Evidence of immune activation has derived from the detection of abnormal levels of proinflammatory cytokines and their receptors in peripheral blood and cerebrospinal fluid from schizophrenic patients. 3-7 Cytokines are involved in normal CNS development as well as in the pathogenesis of many neuro-psychiatric disorders, acting directly on neural cells or modulating neurotransmitter and neuropeptide systems. 8,9 In particular tumor necrosis factor ␣ (TNF␣), depending on its concentration, can exert both neurotrophic and neurotoxic effects and influence neural cell growth and proliferation. 10,11 Moreover, TNF␣ gene is located on the small arm of chromosome 6 (6p21.1-21.3), a locus associated with genetic susceptibility to schizophrenia. 12, 13 We studied the distribution of −G308A TNF␣ gene polymorphism in 84 schizophrenic patients and in 138 healthy volunteers. This biallelic base exchange polymorphism directly affects TNF␣ plasma levels. 14-18 Frequency of the TNF2(A) allele is significantly increased in schizophrenic patients as compared to controls (P = 0.0042). Genotype distribution is also significantly different (P = 0.0024). TNF2 homozygotes are represented only in the patient group (P = 0.002). These data suggest a potential role of TNF␣ as a candidate gene for susceptibility to schizophrenia and suggest that immune dysregulation in schizophrenic patients could also have a genetic component. Molecular Psychiatry (2001) 6, 79-82.

No abstract

Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high-quality research has accumulated that will improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.

No abstract